Skip to main content
Livermore
Livermore
ZHEN

Geode Capital Management, LLC

SEC CIK
0001214717
Latest filing
Aug 12, 2026

RAPT holding history

RAPT Therapeutics, Inc. in every 13F filed by Geode Capital Management, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

RAPT overviewAll 13F holders of RAPTFull Q2 2026 holdings

Shares (Q1 2026)
0
Sold out in Q1 2026
Value
$0
% of portfolio
0.0%
Quarters held
20
Since Q1 2021
Holdings of RAPT by Geode Capital Management, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q1 20260$00.0%−239,790−100.0%Sold outHolders
Q4 2025239,790$8.13M<0.1%+118,326+97.4%AddedHolders
Q3 2025121,464$3.13M<0.1%−18,595−13.3%ReducedHolders
Q2 2025140,059$1.12M<0.1%−1,166,476−89.3%ReducedHolders
Q1 20251,306,535$1.59M<0.1%+589,598+82.2%AddedHolders
Q4 2024716,937$1.13M<0.1%+33,758+4.9%AddedHolders
Q3 2024683,179$1.37M<0.1%−1,534−0.2%ReducedHolders
Q2 2024684,713$2.09M<0.1%+5,497+0.8%AddedHolders
Q1 2024679,216$6.10M<0.1%+9,917+1.5%AddedHolders
Q4 2023669,299$16.6M<0.1%+40,413+6.4%AddedHolders
Q3 2023628,886$10.5M<0.1%+84,936+15.6%AddedHolders
Q2 2023543,950$10.2M<0.1%+15,395+2.9%AddedHolders
Q1 2023528,555$9.70M<0.1%+73,649+16.2%AddedHolders
Q4 2022454,906$9.01M<0.1%+29,763+7.0%AddedHolders
Q3 2022425,143$10.2M<0.1%+18,711+4.6%AddedHolders
Q2 2022406,432$7.42M<0.1%+35,841+9.7%AddedHolders
Q1 2022370,591$8.15M<0.1%+26,577+7.7%AddedHolders
Q4 2021344,014$12.6M<0.1%−2,853−0.8%ReducedHolders
Q3 2021346,867$10.8M<0.1%+119,279+52.4%AddedHolders
Q2 2021227,588$7.24M<0.1%+58,075+34.3%AddedHolders
Q1 2021169,513$3.76M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.